CA3046911A1 - Cannabinoides actifs electroniquement - Google Patents
Cannabinoides actifs electroniquement Download PDFInfo
- Publication number
- CA3046911A1 CA3046911A1 CA3046911A CA3046911A CA3046911A1 CA 3046911 A1 CA3046911 A1 CA 3046911A1 CA 3046911 A CA3046911 A CA 3046911A CA 3046911 A CA3046911 A CA 3046911A CA 3046911 A1 CA3046911 A1 CA 3046911A1
- Authority
- CA
- Canada
- Prior art keywords
- block
- retrieved
- doi
- polyethylene glycol
- pmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3046911A CA3046911A1 (fr) | 2019-06-18 | 2019-06-18 | Cannabinoides actifs electroniquement |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3046911A CA3046911A1 (fr) | 2019-06-18 | 2019-06-18 | Cannabinoides actifs electroniquement |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3046911A1 true CA3046911A1 (fr) | 2020-12-18 |
Family
ID=74036600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3046911A Pending CA3046911A1 (fr) | 2019-06-18 | 2019-06-18 | Cannabinoides actifs electroniquement |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA3046911A1 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11905535B2 (en) | 2019-10-01 | 2024-02-20 | Empyrean Nueroscience, Inc. | Genetic engineering of fungi to modulate tryptamine expression |
| US12104179B2 (en) | 2021-12-31 | 2024-10-01 | Empyrean Neuroscience, Inc. | Genetically modified organisms for producing psychotropic alkaloids |
-
2019
- 2019-06-18 CA CA3046911A patent/CA3046911A1/fr active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11905535B2 (en) | 2019-10-01 | 2024-02-20 | Empyrean Nueroscience, Inc. | Genetic engineering of fungi to modulate tryptamine expression |
| US12104179B2 (en) | 2021-12-31 | 2024-10-01 | Empyrean Neuroscience, Inc. | Genetically modified organisms for producing psychotropic alkaloids |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3046911A1 (fr) | Cannabinoides actifs electroniquement | |
| Pan et al. | Therapeutic applications of metal and metal-oxide nanoparticles: Dermato-cosmetic perspectives | |
| Nuță et al. | Contribution of essential oils to the fight against microbial biofilms—A review | |
| Ahmad et al. | Phytomediated selenium nanoparticles improved physio-morphological, antioxidant, and oil bioactive compounds of sesame under induced biotic stress | |
| Vuko et al. | Chemical composition and new biological activities of essential oil and hydrosol of Hypericum perforatum L. ssp. veronense (Schrank) H. Lindb | |
| Hayek | Chocolate, gut microbiota, and human health | |
| Abbaszadegan et al. | Time‐dependent antibacterial effects of Aloe vera and Zataria multiflora plant essential oils compared to calcium hydroxide in teeth infected with Enterococcus faecalis | |
| ES2118834T3 (es) | Sistema mejorado de penetracion en la piel para la administracion topica mejorada de farmacos. | |
| Pupo et al. | Cytotoxicity of Etch‐and‐Rinse, Self‐Etch, and Universal Dental Adhesive Systems in Fibroblast Cell Line 3T3 | |
| Botsali et al. | Residual HEMA and TEGDMA release and cytotoxicity evaluation of resin‐modified glass ionomer cement and compomers cured with different light sources | |
| KR102216462B1 (ko) | 4-(3-에톡시-4-히드록시페닐)-2-부타논을 포함하는 보존제, 및 이의 화장품 조성물에의 용도 | |
| EP2119425A4 (fr) | Composition dentaire | |
| EP2222789B1 (fr) | Système de polymère de silicone-silice | |
| US20230072395A1 (en) | Composition for keratin fibers | |
| Shanmugam et al. | Biosynthesis of silver nanoparticles from leaf extract of Salvia coccinea and its effects of anti-inflammatory potential in human monocytic THP-1 cells | |
| Kim et al. | Pharmacological and therapeutic activities of Aloe vera and its major active constituent acemannan | |
| Ivanova et al. | Salvia verticillata (L.)—biological activity, chemical profile, and future perspectives | |
| Devkota et al. | Pharmacology of plant polyphenols in human health and diseases | |
| Kassu et al. | Ethnomedical aspects of the commonly used toothbrush sticks in Ethiopia. | |
| Sakhanokho et al. | Hedychium essential oils: Composition and uses | |
| Subbiya et al. | Evaluation of the Antibacterial Activity of three Guttapercha Solvents against Enterococcus Faecalis | |
| WO2008115961A2 (fr) | Composition à libération prolongée | |
| Baeza-Squiban et al. | Effects of deltamethrin and its commercial formulation DECIS on different cell types in vitro: Cytotoxicity, cellular binding, and intracellular localization | |
| Badzian et al. | In vitro rooting of clonal propagated miniature rose cultivars | |
| CN108714141A (zh) | 硅酮疤痕喷剂 |